CHMP calls for more research into possible links between vaccination and narcolepsy in young
This article was originally published in Scrip
Having reviewed further data from Finland on the suspected link between narcolepsy in children and adolescents and GlaxoSmithKline's pandemic flu vaccine Pandemrix, the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has concluded that while the new evidence raises additional concerns, the data are still insufficient to establish a causal relationship.
You may also be interested in...
Cambridge, UK-based Healx has concluded a $56m series B round, led by Atomico, to put up to 50 potential rare disease treatments into the clinic within two years using its AI/ML platform.
Tapping into the ability of arenaviruses to deliver prolonged local immune activation, rapid regression of localized and metastatic cancers, and long-term disease control, Essen, Germany-based start-up Abalos Therapeutics has raised €12m to advance its lead candidates towards clinical testing.
Celgene agrees to pay $75m upfront for options to three Immatics TCR-T targets for solid tumors. Deal could be worth up to $1.59bn to the German biotech, which also retains option to co-develop and co-fund certain licensed products.